NasdaqGM - Nasdaq Real Time Price USD
NewAmsterdam Pharma Company N.V. (NAMS)
20.26
+0.12
+(0.62%)
As of 2:52:28 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,541,497 | 35 |
| Sales | 1,963,268 | 17 |
| Net Shares Purchased (Sold) | -421,771 | 52 |
| Total Insider Shares Held | 433.36k | -- |
| % Net Shares Purchased (Sold) | -49.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MARINO MICHAEL F III Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2025 |
| LANGE LOUIS G M.D., PH.D. Director | -- | Indirect | -- | May 30, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 18.70 per share. | Direct | 1,870,000 | May 15, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Conversion of Exercise of derivative security at price 10.00 per share. | Direct | 1,000,000 | May 15, 2025 |
| LANGE LOUIS G M.D., PH.D. Director | -- | Indirect | -- | May 1, 2025 |
| GULFO ADELE MADELYN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 15, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 16.06 per share. | Direct | 1,606,000 | Apr 15, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Conversion of Exercise of derivative security at price 10.00 per share. | Direct | 1,000,000 | Apr 15, 2025 |
| LANGE LOUIS G M.D., PH.D. Director | -- | Indirect | -- | Apr 14, 2025 |
| DAVIDSON MICHAEL H Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2025 |
| KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Mar 26, 2025 |
| TOPPER JAMES N Director | Purchase at price 22.49 per share. | Indirect | 25,521 | Mar 26, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 22.56 per share. | Direct | 373,120 | Mar 26, 2025 |
| DAVIDSON MICHAEL H Chief Executive Officer | Sale at price 22.56 per share. | Direct | 276,540 | Mar 26, 2025 |
| LANGE LOUIS G M.D., PH.D. Director | -- | Direct | -- | Mar 26, 2025 |
| DAVIDSON MICHAEL H Chief Executive Officer | -- | Direct | -- | Mar 26, 2025 |
| KLING DOUGLAS F Chief Operating Officer | -- | Direct | -- | Mar 26, 2025 |
| KOOIJ LOUISE FREDERIKA Officer | -- | Direct | -- | Mar 26, 2025 |
| KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director | -- | Direct | -- | Mar 26, 2025 |
| KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director | -- | Indirect | -- | Mar 24, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 23.34 per share. | Direct | 2,334,000 | Mar 17, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Conversion of Exercise of derivative security at price 10.00 per share. | Direct | 118,880 | Mar 17, 2025 |
| TOPPER JAMES N Director | Purchase at price 21.02 per share. | Indirect | 84,203 | Mar 4, 2025 |
| KOOIJ LOUISE FREDERIKA Officer | Sale at price 20.37 per share. | Direct | 3,055,500 | Mar 4, 2025 |
| KOOIJ LOUISE FREDERIKA Officer | -- | Direct | -- | Mar 4, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 19.12 - 20.04 per share. | Direct | 1,995,519 | Feb 19, 2025 |
| KLING DOUGLAS F Chief Operating Officer | -- | Direct | -- | Feb 19, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 20.78 - 21.77 per share. | Direct | 1,477,206 | Jan 30, 2025 |
| KLING DOUGLAS F Chief Operating Officer | -- | Direct | -- | Jan 30, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Sale at price 21.45 - 22.61 per share. | Direct | 2,899,882 | Jan 28, 2025 |
| SOMAIYA MAYUR IAN Chief Financial Officer | Sale at price 21.45 - 22.61 per share. | Direct | 1,381,891 | Jan 28, 2025 |
| KLING DOUGLAS F Chief Operating Officer | -- | Direct | -- | Jan 28, 2025 |
| SOMAIYA MAYUR IAN Chief Financial Officer | Conversion of Exercise of derivative security at price 9.26 per share. | Direct | 573,037 | Jan 28, 2025 |
| LANGE LOUIS G M.D., PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| JONES WILLIAM A JR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| LEWIS WILLIAM H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| SMITHER JOHN W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| DAVIDSON MICHAEL H Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| KLING DOUGLAS F Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| MCKENNA MARK C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| SOMAIYA MAYUR IAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| VAN DER KAMP HILDE JOHANNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| KOOIJ LOUISE FREDERIKA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| AUDET JULIETTE BERANGERE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| FORGROWTH NAP B.V. Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.54 per share. | Indirect | 762,174 | Dec 30, 2024 |
| FORGROWTH NAP B.V. Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.95 - 26.01 per share. | Indirect | 1,945,918 | Dec 27, 2024 |
| FORGROWTH NAP B.V. Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.49 - 26.13 per share. | Indirect | 2,329,520 | Dec 24, 2024 |
| FORGROWTH NAP B.V. Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.45 - 26.55 per share. | Indirect | 4,066,714 | Dec 19, 2024 |
| FORGROWTH NAP B.V. Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.00 - 26.45 per share. | Indirect | 2,996,156 | Dec 17, 2024 |
Related Tickers
DYN Dyne Therapeutics, Inc.
14.15
-3.74%
NRIX Nurix Therapeutics, Inc.
12.60
-1.45%
CLYM Climb Bio, Inc.
1.3550
-2.52%
BCAX Bicara Therapeutics Inc.
11.57
+0.57%
ANAB AnaptysBio, Inc.
22.78
-3.88%
TECX Tectonic Therapeutic, Inc.
23.66
+2.60%
PTGX Protagonist Therapeutics, Inc.
55.48
+2.02%
TRVI Trevi Therapeutics, Inc.
6.51
-7.86%
IDYA IDEAYA Biosciences, Inc.
21.65
-0.37%
MLYS Mineralys Therapeutics, Inc.
16.13
+0.06%